Form 4 for NVAX NOVAVAX INC
Accepted 2021-09-28 00:00:00 ET · period of report 2021-09-26 · accession 0001209191-21-057940 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-09-28 | 2021-09-26 | NVAX | Herrmann John A III | EVP, CLO | M - OptEx | — | +666 | 1,969 | +51% | — |
| D | 2021-09-28 | 2021-09-26 | NVAX | Herrmann John A III | EVP, CLO | F - Tax | $248.16 | -1,919 | 2,760 | -41% | -$476.2K |
| DI | 2021-09-28 | 2021-09-26 | NVAX | Herrmann John A III | EVP, CLO | F - Tax | $248.16 | -222 | 1,747 | -11% | -$55.1K |
| D | 2021-09-28 | 2021-09-26 | NVAX | Herrmann John A III | EVP, CLO | M - OptEx | — | +3,973 | 4,679 | +563% | — |
| DI | 2021-09-28 | 2021-09-26 | NVAX | Herrmann John A III | EVP, CLO | M - OptEx | $0.00 | -666 | 667 | -50% | $0 |
| D | 2021-09-28 | 2021-09-26 | NVAX | Herrmann John A III | EVP, CLO | M - OptEx | $0.00 | -3,973 | 3,973 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-26 | M | A | 666 | — | 1,969 | I | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F2) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2021-09-26 | F | D | 1,919 | $248.16 | 2,760 | D By spouse | — | — | |
| 3 | Common | Common Stock | 2021-09-26 | F | D | 222 | $248.16 | 1,747 | I | — | — | (F2) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
| 4 | Common | Common Stock | 2021-09-26 | M | A | 3,973 | — | 4,679 | D By spouse | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| 5 | Derivative | Restricted Stock Units | 2021-09-26 | M | D | 666 | $0.00 | 667 | I | — · — to — | 666 Common Stock | (F2) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F4) The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service with the Company through such vesting date. |
| 6 | Derivative | Restricted Stock Units | 2021-09-26 | M | D | 3,973 | $0.00 | 3,973 | D By spouse | — · — to — | 3,973 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. (F3) The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the September 26, 2019 grant date (the "Grant Date"), in each case subject to continued employment through such vesting date. |